Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2001 Apr 15;355(Pt 2):289–296. doi: 10.1042/0264-6021:3550289

Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding.

M Chen 1, S Narumiya 1, T Masaki 1, T Sawamura 1
PMCID: PMC1221738  PMID: 11284714

Abstract

Lectin-like oxidized low-density-lipoprotein (oxLDL) receptor-1 (LOX-1) is a cell-surface endocytosis receptor for atherogenic oxLDL, which is highly expressed in endothelial cells. Recent studies suggest that it may play significant roles in atherogenesis. LOX-1 is a type-II membrane protein that structurally belongs to the C-type lectin family molecules. This study was designed to characterize the specific domain on LOX-1 that recognizes oxLDL. Truncation of the lectin domain of LOX-1 abrogated oxLDL-binding activity. Deletion of the utmost C-terminal ten amino acid residues (261-270) was enough to disrupt the oxLDL-binding activity. Substitutions of Lys-262 and/or Lys-263 with Ala additively attenuated the activity. Serial-deletion analysis showed that residues up to 265 are required for the expression of minimal binding activity, although deletion of the C-terminal three residues (268-270) still retained full binding activity. Consistently, these alterations in LOX-1 impaired the recognition by a functionally blocking monoclonal antibody for LOX-1. These data demonstrated the distinct role of the lectin domain as the functional domain recognizing LOX-1 ligand. The conserved C-terminal residues of lectin-like domain are essential for binding oxLDL. Particularly, the basic amino acid pair is important for the binding.

Full Text

The Full Text of this article is available as a PDF (258.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson L., Freeman M. W. Functional changes in scavenger receptor binding conformation are induced by charge mutants spanning the entire collagen domain. J Biol Chem. 1998 Jul 31;273(31):19592–19601. doi: 10.1074/jbc.273.31.19592. [DOI] [PubMed] [Google Scholar]
  2. Aoyama T., Chen M., Fujiwara H., Masaki T., Sawamura T. LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells. FEBS Lett. 2000 Feb 11;467(2-3):217–220. doi: 10.1016/s0014-5793(00)01154-6. [DOI] [PubMed] [Google Scholar]
  3. Aoyama T., Fujiwara H., Masaki T., Sawamura T. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells. J Mol Cell Cardiol. 1999 Dec;31(12):2101–2114. doi: 10.1006/jmcc.1999.1041. [DOI] [PubMed] [Google Scholar]
  4. Aoyama T., Sawamura T., Furutani Y., Matsuoka R., Yoshida M. C., Fujiwara H., Masaki T. Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene. Biochem J. 1999 Apr 1;339(Pt 1):177–184. [PMC free article] [PubMed] [Google Scholar]
  5. Boyington J. C., Riaz A. N., Patamawenu A., Coligan J. E., Brooks A. G., Sun P. D. Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors. Immunity. 1999 Jan;10(1):75–82. doi: 10.1016/s1074-7613(00)80008-4. [DOI] [PubMed] [Google Scholar]
  6. Chen M., Kakutani M., Minami M., Kataoka H., Kume N., Narumiya S., Kita T., Masaki T., Sawamura T. Increased expression of lectin-like oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):1107–1115. doi: 10.1161/01.atv.20.4.1107. [DOI] [PubMed] [Google Scholar]
  7. Cominacini L., Pasini A. F., Garbin U., Davoli A., Tosetti M. L., Campagnola M., Rigoni A., Pastorino A. M., Lo Cascio V., Sawamura T. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem. 2000 Apr 28;275(17):12633–12638. doi: 10.1074/jbc.275.17.12633. [DOI] [PubMed] [Google Scholar]
  8. Dejager S., Mietus-Snyder M., Friera A., Pitas R. E. Dominant negative mutations of the scavenger receptor. Native receptor inactivation by expression of truncated variants. J Clin Invest. 1993 Aug;92(2):894–902. doi: 10.1172/JCI116664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Doi T., Higashino K., Kurihara Y., Wada Y., Miyazaki T., Nakamura H., Uesugi S., Imanishi T., Kawabe Y., Itakura H. Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors. J Biol Chem. 1993 Jan 25;268(3):2126–2133. [PubMed] [Google Scholar]
  10. Draude G., Hrboticky N., Lorenz R. L. The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin. Biochem Pharmacol. 1999 Feb 15;57(4):383–386. doi: 10.1016/s0006-2952(98)00313-x. [DOI] [PubMed] [Google Scholar]
  11. Holvoet P. Endothelial dysfunction, oxidation of low-density lipoprotein, and cardiovascular disease. Ther Apher. 1999 Nov;3(4):287–293. doi: 10.1046/j.1526-0968.1999.00169.x. [DOI] [PubMed] [Google Scholar]
  12. Hoshikawa H., Sawamura T., Kakutani M., Aoyama T., Nakamura T., Masaki T. High affinity binding of oxidized LDL to mouse lectin-like oxidized LDL receptor (LOX-1). Biochem Biophys Res Commun. 1998 Apr 28;245(3):841–846. doi: 10.1006/bbrc.1998.8526. [DOI] [PubMed] [Google Scholar]
  13. Kakutani M., Masaki T., Sawamura T. A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1. Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):360–364. doi: 10.1073/pnas.97.1.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kataoka H., Kume N., Miyamoto S., Minami M., Moriwaki H., Murase T., Sawamura T., Masaki T., Hashimoto N., Kita T. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation. 1999 Jun 22;99(24):3110–3117. doi: 10.1161/01.cir.99.24.3110. [DOI] [PubMed] [Google Scholar]
  15. Kataoka H., Kume N., Miyamoto S., Minami M., Murase T., Sawamura T., Masaki T., Hashimoto N., Kita T. Biosynthesis and post-translational processing of lectin-like oxidized low density lipoprotein receptor-1 (LOX-1). N-linked glycosylation affects cell-surface expression and ligand binding. J Biol Chem. 2000 Mar 3;275(9):6573–6579. doi: 10.1074/jbc.275.9.6573. [DOI] [PubMed] [Google Scholar]
  16. Kume N., Murase T., Moriwaki H., Aoyama T., Sawamura T., Masaki T., Kita T. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res. 1998 Aug 10;83(3):322–327. doi: 10.1161/01.res.83.3.322. [DOI] [PubMed] [Google Scholar]
  17. Li D., Mehta J. L. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation. 2000 Jun 27;101(25):2889–2895. doi: 10.1161/01.cir.101.25.2889. [DOI] [PubMed] [Google Scholar]
  18. Li D., Mehta J. L. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):1116–1122. doi: 10.1161/01.atv.20.4.1116. [DOI] [PubMed] [Google Scholar]
  19. Mehta J. L., Li D. Y. Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun. 1998 Jul 30;248(3):511–514. doi: 10.1006/bbrc.1998.9004. [DOI] [PubMed] [Google Scholar]
  20. Minami M., Kume N., Kataoka H., Morimoto M., Hayashida K., Sawamura T., Masaki T., Kita T. Transforming growth factor-beta(1) increases the expression of lectin-like oxidized low-density lipoprotein receptor-1. Biochem Biophys Res Commun. 2000 Jun 7;272(2):357–361. doi: 10.1006/bbrc.2000.2778. [DOI] [PubMed] [Google Scholar]
  21. Moriwaki H., Kume N., Kataoka H., Murase T., Nishi E., Sawamura T., Masaki T., Kita T. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-alpha. FEBS Lett. 1998 Nov 27;440(1-2):29–32. doi: 10.1016/s0014-5793(98)01414-8. [DOI] [PubMed] [Google Scholar]
  22. Moriwaki H., Kume N., Sawamura T., Aoyama T., Hoshikawa H., Ochi H., Nishi E., Masaki T., Kita T. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol. 1998 Oct;18(10):1541–1547. doi: 10.1161/01.atv.18.10.1541. [DOI] [PubMed] [Google Scholar]
  23. Nagase M., Hirose S., Sawamura T., Masaki T., Fujita T. Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats. Biochem Biophys Res Commun. 1997 Aug 28;237(3):496–498. doi: 10.1006/bbrc.1997.7176. [DOI] [PubMed] [Google Scholar]
  24. Oka K., Sawamura T., Kikuta K., Itokawa S., Kume N., Kita T., Masaki T. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9535–9540. doi: 10.1073/pnas.95.16.9535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pearce S. F., Roy P., Nicholson A. C., Hajjar D. P., Febbraio M., Silverstein R. L. Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain. J Biol Chem. 1998 Dec 25;273(52):34875–34881. doi: 10.1074/jbc.273.52.34875. [DOI] [PubMed] [Google Scholar]
  26. Puente Navazo M. D., Daviet L., Ninio E., McGregor J. L. Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL). Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):1033–1039. doi: 10.1161/01.atv.16.8.1033. [DOI] [PubMed] [Google Scholar]
  27. Renedo M., Arce I., Montgomery K., Roda-Navarro P., Lee E., Kucherlapati R., Fernández-Ruiz E. A sequence-ready physical map of the region containing the human natural killer gene complex on chromosome 12p12.3-p13.2. Genomics. 2000 Apr 15;65(2):129–136. doi: 10.1006/geno.2000.6163. [DOI] [PubMed] [Google Scholar]
  28. Sawamura T., Kume N., Aoyama T., Moriwaki H., Hoshikawa H., Aiba Y., Tanaka T., Miwa S., Katsura Y., Kita T. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997 Mar 6;386(6620):73–77. doi: 10.1038/386073a0. [DOI] [PubMed] [Google Scholar]
  29. Steinbrecher U. P. Receptors for oxidized low density lipoprotein. Biochim Biophys Acta. 1999 Jan 4;1436(3):279–298. doi: 10.1016/s0005-2760(98)00127-1. [DOI] [PubMed] [Google Scholar]
  30. Terpstra V., van Amersfoort E. S., van Velzen A. G., Kuiper J., van Berkel T. J. Hepatic and extrahepatic scavenger receptors: function in relation to disease. Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):1860–1872. doi: 10.1161/01.atv.20.8.1860. [DOI] [PubMed] [Google Scholar]
  31. Tormo J., Natarajan K., Margulies D. H., Mariuzza R. A. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature. 1999 Dec 9;402(6762):623–631. doi: 10.1038/45170. [DOI] [PubMed] [Google Scholar]
  32. Yamanaka S., Zhang X. Y., Miura K., Kim S., Iwao H. The human gene encoding the lectin-type oxidized LDL receptor (OLR1) is a novel member of the natural killer gene complex with a unique expression profile. Genomics. 1998 Dec 1;54(2):191–199. doi: 10.1006/geno.1998.5561. [DOI] [PubMed] [Google Scholar]
  33. Yoshida H., Kondratenko N., Green S., Steinberg D., Quehenberger O. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J. 1998 Aug 15;334(Pt 1):9–13. doi: 10.1042/bj3340009. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES